Paraneoplastic neurological syndrome in onset of Hodgkin lymphoma

Abstract

Hodgkin lymphoma is a malignant disease with clonal proliferation of B-cells and high-level reactive inflammatory microenvironment. The main clinical sings are lymphadenopathy and toxic symptoms. Neurological symptoms as usual can be a result of compression or tumor infiltration of nervous structures. The primary damage of CNS occurs from 0,2% to 0,5% of all cases HL.

Paraneoplastic neurological syndrome is a group of rare (an average 1 case on 10000 patients) neurological disorders against the background of oncological process. The pathophysiologic mechanism is due to production of antibody which is both to tumor cells and nerve cells. These antibodies are called onconeural autoantibodies. The hallmark which make diagnostics harder is the fact that onconeural autoantibodies rare take place in patients with lymphomas unless anti-Tr and anti-mGluR1 in patients with limbic encephalitis or paraneoplastic cerebellar degeneration.

There are two case reports about patients with PNS in onset of Hodgkin lymphoma in article.

Keywords

damage of CNS / Hodgkin lymphoma / paraneoplastic syndrome

References

[1] Rossiiskie klinicheskie rekomendatsii po diagnostike i leche¬niyu limfoproliferativnykh zabolevanii. Ed. by I.V. Poddubnaya, V.G. Savchenko. Moscow: Media Medika; 2013. (In Russ.)

[2] Российские клинические рекомендации по диагностике и лечению лимфопролиферативных заболеваний / под ред. И.В. Поддубной, В.Г. Савченко. Москва: Медиа Медика, 2013.

[3] Demina EA. Hodgkin’s lymphoma: since Thomas Hodgkin up to modern days. Clinical Oncohematology. 2008;1(2):114–118. (In Russ.)

[4] Демина Е.А. Лимфома Ходжкина: от Томаса Ходжкина до наших дней // Клиническая онкогематология. 2008. Т. 1, № 2. С.114–118.

[5] Al’-Radi LS, Baryakh EA, Belousova IEh, et al. Klinicheskie rekomendatsii po diagnostike i lecheniyu limfoproliferativnykh zabolevanii. Moscow; 2014. (In Russ.)

[6] Аль-Ради Л.С., Барях Е.А., Белоусова И.Э. и др. Клинические рекомендации по диагностике и лечению лимфопролиферативных заболеваний. Москва, 2014.

[7] Rumyantsev AG, Myakova NV, Maschan AA. Federal guidelines for the diagnosis and treatment of Hodgkin’s lymphoma (Lymphogranulomatosis). Russian Journal of Pediatric Hematology аnd Oncology. 2015;2(4):79–90. (In Russ.). DOI: 10.17650/2311-1267-2015-2-4-79-90

[8] Румянцев А.Г., Мякова Н.В., Масчан А.А. Федеральные клинические рекомендации по диагностике и лечению лимфомы Ходжкина (лимфогранулематоз) // Российский журнал детской гематологии и онкологии. 2015. Т. 2, № 4. С. 79–90. DOI: 10.17650/2311-1267-2015-2-4-79-90

[9] Gerstner ER, Abrey LE, Schiff D, et al. CNS Hodgkin lymphoma. Blood. 2008;112(5):1658–1661. DOI: 10.1182/blood-2008-04-151563

[10] Gerstner E.R., Abrey L.E., Schiff D. et al. CNS Hodgkin lymphoma // Blood. 2008. Vol. 112, No. 5. P. 1658–1661. DOI: 10.1182/blood-2008-04-151563

[11] Valiev TT, Guseva NA, Solozhentseva KD. Clinical profile and differential diagnosis of classical paraneoplastic neurologic syndromes in lymphomas. Onkopediatria. 2017;4(3):183–191. (In Russ.). DOI: 10.15690/onco.v4i3.1749

[12] Валиев Т.Т., Гусева Н.А., Соложенцева К.Д. Клиническая характеристика и дифференциальная диагностика классических паранеопластических неврологических синдромов при лимфоме // Онкопедиатрия. 2017. Т. 3, № 4. С.183–191. DOI: 10.15690/onco.v4i3.1749

[13] Graus F, Ariño H, Dalmau J. Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas. Blood. 2014;123(21):3230–3238. DOI: 10.1182/blood-2014-03-537506

[14] Graus F., Ariño H., Dalmau J. Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas // Blood. 2014. Vol. 123, No. 21. P. 3230–3238. DOI: 10.1182/blood-2014-03-537506

[15] Shnayder NA, Dykhno YuA, Ezhikova VV. Clinical heterogeneity of paraneoplastic neurological syndrome. Siberian Journal of Oncology. 2011;(3):82–90. (In Russ.)

[16] Шнайдер Н.А., Дыхно Ю.А., Ежикова В.В. Клиническая гетерогенность паранеопластического неврологического синдрома // Сибирский онкологический журнал. 2011. № 3. С. 82–90.

[17] Davydovskaya MV, Boĭko AN, Beliaeva IA, et al. Autoimmune encephalitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(4):95–101. (In Russ.). DOI: 10.17116/jnevro20151154195-101

[18] Давыдовская М.В., Бойко А.Н., Беляева И.А. и др. Ауто¬иммунные энцефалиты // Журнал неврологии и психиатрии им. С.С. Корсакова. 2015. Т. 115, № 4. С. 95–101. DOI: 10.17116/jnevro20151154195-101

[19] Tandra PK, Kallam A, Bendi VS, et al. Paraneoplastic manifestations of lymphoproliferative neoplasms. Lymphoma and Chronic Lymphocytic Leukemias. 2016;(6):21–33. DOI:10.4137/LCLL.S38507

[20] Tandra P.K., Kallam A., Bendi V.S. et al. Paraneoplastic manifestations of lymphoproliferative neoplasms // Lymphoma and Chronic Lymphocytic Leukemias. 2016. No. 6. P. 21–33. DOI:10.4137/LCLL.S38507

[21] Krasnov MYu, Pavlov EV, Ershova MV, et al. The range of neurological syndromes associated with glutamic acid decar¬boxylase antibodies. Annals of Clinical and Experimental Neurology. 2015;9(4):37–41. (In Russ.)

[22] Краснов М.Ю., Павлов Э.В., Ершова М.В. и др. Спектр неврологических синдромов, ассоциированных с антителами к глутамат-декарбоксилазе // Анналы клинической и экспериментальной неврологии. 2015. Т. 9, № 4. С. 37–41.

RIGHTS & PERMISSIONS

Pavlyuchenko E.S., Mirsaitov A.A., Diakonova M.N., Karev E.A.